CCCC

2.4952.25%
UK

Utpal Koppikar

Independent Director

Mr. Utpal Koppikar, M.B.A., serves as Chief Financial Officer of Verily Life Sciences LLC since February 2023. He serves as Independent Director of C4 Therapeutics, Inc. since March 2022. He is Independent Director of Insmed Incorporated from October 19, 2026. He served as Director at Granular Insurance Company. He served as Chief Financial Officer of Atara Biotherapeutics, Inc. since June 7, 2018 until March 31, 2023 and served as Executive Vice President since February 2022 until March 31, 2023. From June 2018 to February 2022, Mr. Koppikar served as Senior Vice President at Atara Biotherapeutics, Inc. Mr. Koppikar oversees finance, information technology and investor relations functions and is responsible for executing the company’s strategy as a member of the senior leadership team. Prior to serving as Atara’s chief financial officer and serves as its Senior Vice President since 2019. Mr. Koppikar served as a Director of Flexion Therapeutics, Inc. since July 9, 2021 until its sale to Pacira BioSciences, Inc. in November 2021. Mr. Koppikar held several senior financial leadership positions at Gilead Sciences from June 2011 to June 2018, including as Vice President of Corporate and Operations Finance and as Vice President of Finance Europe, Middle East and Australia, where he led the financial integration of Kite Pharma and played an integral role in pricing. Mr. Koppikar began his career in life sciences at Amgen, Inc., where he held multiple positions of increasing seniority, ultimately serving as executive director of financial planning and analysis. Prior to Gilead, from January 2001 to June 2011, he served in multiple finance roles of increasing responsibility at Amgen. He has served as Chief Financial Officer (“CFO”) at Verily Health Inc., a healthcare data intelligence company focused on enabling more personal, predictive and precise health solutions, since April 2023, where he is responsible for the finance, real estate and workplace services and corporate development functions. He began his career at Honeywell Aerospace (formerly AlliedSignal). Mr. Koppikar earned his B.S. in aerospace engineering at the University of Maryland and received a M.S. in aeronautical and astronautical engineering from Stanford University. He also holds an MBA in finance and marketing from Anderson School of Management at University of California, Los Angeles.

Positions